{"id":13925,"date":"2024-01-22T00:58:22","date_gmt":"2024-01-21T19:28:22","guid":{"rendered":"https:\/\/timesofpowerandvoice.com\/?p=13925"},"modified":"2024-01-22T00:58:23","modified_gmt":"2024-01-21T19:28:23","slug":"indian-immunologicals-ltd-iil-rolls-out-indias-first-indigenously-developed-hepatitis-a-vaccine-havisure","status":"publish","type":"post","link":"https:\/\/timesofpowerandvoice.com\/?p=13925","title":{"rendered":"Indian Immunologicals Ltd (IIL) rolls out India\u2019s first indigenously developed Hepatitis A Vaccine \u2018Havisure\u00ae\u2019"},"content":{"rendered":"\n

India achieves Self-sufficiency for Hepatitis A vaccine, true example of Atma Nirbhar Bharat<\/strong><\/p>\n\n\n\n

Pune (Voice news service):-<\/strong>\u00a0Indian Immunologicals Ltd<\/strong><\/a>\u00a0(IIL)<\/strong>\u00a0a wholly owned subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India marks a historic moment in public health with the\u00a0launch of India\u2019s first indigenously developed Hepatitis A vaccine \u201cHavisure\u00ae<\/sup>\u201d.<\/strong>\u00a0The vaccine represents a significant step forward in India’s fight against Hepatitis A and is poised to make a substantial contribution to public health.<\/p>\n\n\n\n

The new vaccine, Havisure\u00ae<\/sup> is the result of extensive research and development efforts by IIL’s dedicated team of scientists and researchers. This indigenously developed vaccine is poised to play a crucial role in preventing Hepatitis A, a highly contagious liver infection that poses a significant public health challenge. Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.<\/p>\n\n\n\n

This Novel Vaccine launch event was held today at Hyatt Place, Hyderabad. Chief guests were Shri Nagaraj Karpan, MLA and Shri Ajay Mishra, IAS-Chairman Indian Redcross Society, Telangana.<\/p>\n\n\n\n

Speaking on the occasion, Dr. K Anand Kumar, Managing Director, Indian Immunologicals Ltd <\/strong>shared “The launch of Havisure\u00ae<\/sup> is a testament to our commitment to advancing healthcare solutions for the nation. Currently Hepatitis A vaccines are imported into our country and <\/em>as <\/em>a true meaning of Atma Nirbhar Bharat, IIL has tirelessly put in efforts and developed India\u2019s 1st<\/sup> vaccine for Hepatitis A<\/em>.<\/em> The vaccine Havisure\u00ae has undergoneextensive clinical trials in 8 centers and has proven to be safe and efficacious. The vaccine is comparable to the world\u2019s leading vaccine sold by a multinational. With Havisure\u00ae<\/sup>, we aim to contribute significantly to the prevention of this infectious disease. IIL launching three vaccines in a single year is itself a big achievement and full credit to my team<\/em>.\u201d<\/p>\n\n\n\n

\u201cHavisure\u201d is set to play a crucial role to protect against the Hepatitis A virus, which primarily affects the liver. The vaccine is effective in preventing the disease and is recommended for children in the routine immunization. It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.<\/p>\n\n\n\n

Discussing on manufacturing capabilities of IIL, Dr. Priyabrata Pattnaik, Dy. Managing Director-IIL<\/strong> said, \u201cThe company has considerably invested in state-of-the-art manufacturing facilities to scale up production and meet the growing demand for Hepatitis A vaccine. As part of the launch, IIL will be collaborating with healthcare professionals, corporate hospitals, and government agencies to promote awareness about Hepatitis A and the importance of both paediatric, adolescent & adult vaccination<\/em>\u201d.<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

India achieves Self-sufficiency for Hepatitis A vaccine, true example of Atma Nirbhar Bharat Pune (Voice news service):-\u00a0Indian Immunologicals Ltd\u00a0(IIL)\u00a0a wholly owned subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India marks a historic moment in public health with the\u00a0launch of India\u2019s first indigenously developed Hepatitis A vaccine \u201cHavisure\u00ae\u201d.\u00a0The vaccine represents […]<\/p>\n","protected":false},"author":1,"featured_media":13926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[],"class_list":["post-13925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/posts\/13925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13925"}],"version-history":[{"count":1,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/posts\/13925\/revisions"}],"predecessor-version":[{"id":13927,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/posts\/13925\/revisions\/13927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=\/wp\/v2\/media\/13926"}],"wp:attachment":[{"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/timesofpowerandvoice.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}